Metabolic syndrome in Argentine women: ATPIII, IDF, IDF/AHA/NHLBI; What criterion should be used?

被引:2
作者
Soutelo, Jimena [1 ]
Saban, Melina [1 ]
Quevedo, Virginia [1 ]
Gandur, Eugenia [1 ]
Paris, Analia [1 ]
Alba, Paola [1 ]
Gonzalez, Julia [1 ]
Barbero, Maria [1 ]
Frizt, Clara [1 ]
Faraj, Gabriel [1 ]
机构
[1] Argentine Fed Police Churruca Visca Hosp, Endocrinol Serv Med Complex PFA, Buenos Aires, DF, Argentina
关键词
Metabolic syndrome in post-menopausal women; risk factors in post-menopause; diagnostic criteria of metabolic syndrome; INTERNATIONAL-DIABETES-FEDERATION; POSTMENOPAUSAL HORMONE-THERAPY; INDEPENDENT RISK-FACTOR; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; BLOOD-PRESSURE; MENOPAUSE; AGE; PREVALENCE; ADULTS;
D O I
10.3109/09513590.2010.501883
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. The menopause and the metabolic syndrome (MS) are related with the increase of the risk of cardiovascular diseases. Objectives. To evaluate the existence of metabolic risk factors and the prevalence of MS in pre- and post-menopausal women. Subjects. 253 women: 120 pre-menopausal and 133 post-menopausal. Anthropometric, arterial pressure and waist circumference measurements were carried out. Glycaemia, lipids, creatinine, hepatogram, uric acid and thyroid-stimulating hormone were dosed. Results. Statistical higher registries of arterial pressure, levels of glycaemia, total cholesterol, low-density lipoprotein, triglycerides and TG/high-density lipoprotein relation were observed among post-menopausal patients. As regards this group, the MS diagnosis was considerably higher, being the same by all the criteria. Conclusions. We found more prevalence of cardiometabolic and MS risk factors among the group of postmenopausal patients. The responsible mechanisms would respond to the secondary hypoestrogenaemia at the cease of the ovarian function. Because of this fact, menopausal women should be considered a risk group for the development of MS.
引用
收藏
页码:448 / 451
页数:4
相关论文
共 25 条
  • [21] Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
    Rossouw, Jacques E.
    Prentice, Ross L.
    Manson, Joann E.
    Wu, LieLing
    Barad, David
    Barnabei, Vanessa M.
    Ko, Marcia
    LaCroix, Andrea Z.
    Margolis, Karen L.
    Stefanick, Marcia L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (13): : 1465 - 1477
  • [22] Snieder H, 1997, AM J HUM GENET, V60, P638
  • [23] Blood pressure through aging and menopause
    Taddei, S.
    [J]. CLIMACTERIC, 2009, 12 : 36 - 40
  • [24] Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight - the Chin-Shan community cardiovascular cohort study
    Torng, PL
    Su, TC
    Sung, FC
    Chien, KL
    Huang, SC
    Chow, SN
    Lee, YT
    [J]. ATHEROSCLEROSIS, 2002, 161 (02) : 409 - 415
  • [25] Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus
    Wilson, PWF
    D'Agostino, RB
    Parise, H
    Sullivan, L
    Meigs, JB
    [J]. CIRCULATION, 2005, 112 (20) : 3066 - 3072